HK1010684A1 - Modified proteins and their use for controlling viral infections. - Google Patents

Modified proteins and their use for controlling viral infections.

Info

Publication number
HK1010684A1
HK1010684A1 HK98111473A HK98111473A HK1010684A1 HK 1010684 A1 HK1010684 A1 HK 1010684A1 HK 98111473 A HK98111473 A HK 98111473A HK 98111473 A HK98111473 A HK 98111473A HK 1010684 A1 HK1010684 A1 HK 1010684A1
Authority
HK
Hong Kong
Prior art keywords
modified proteins
functional groups
polypeptides
basic
viral infections
Prior art date
Application number
HK98111473A
Other languages
English (en)
Inventor
Robert Walter Jansen
Dirk Klaas Fokke Meijer
Grietje Molema
Erik Desire Alice De Clercq
Rudi Wilfried Jan Pauwels
Dominique Schols
Original Assignee
Rijksuniverisiteit Te Groninge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniverisiteit Te Groninge filed Critical Rijksuniverisiteit Te Groninge
Publication of HK1010684A1 publication Critical patent/HK1010684A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98111473A 1991-03-11 1998-10-22 Modified proteins and their use for controlling viral infections. HK1010684A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100434A NL9100434A (nl) 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
PCT/NL1992/000036 WO1992015316A1 (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections

Publications (1)

Publication Number Publication Date
HK1010684A1 true HK1010684A1 (en) 1999-06-25

Family

ID=19859005

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111473A HK1010684A1 (en) 1991-03-11 1998-10-22 Modified proteins and their use for controlling viral infections.

Country Status (10)

Country Link
EP (1) EP0575432B1 (xx)
JP (1) JP2690813B2 (xx)
AT (1) ATE284222T1 (xx)
AU (1) AU1566392A (xx)
DE (1) DE69233455T2 (xx)
DK (1) DK0575432T3 (xx)
ES (1) ES2233923T3 (xx)
HK (1) HK1010684A1 (xx)
NL (1) NL9100434A (xx)
WO (1) WO1992015316A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010799A1 (en) * 1991-11-27 1993-06-10 Immtech International Incorporated Method of treating viral infections
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
AU4835693A (en) * 1993-08-13 1995-03-14 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
WO1997034619A1 (en) * 1996-03-20 1997-09-25 New York Blood Center Methods of treating herpes or chlamydia
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus
EP1426382A1 (en) * 2002-12-06 2004-06-09 Aventis Behring GmbH Antiviral human serum albumin
EP1625851A4 (en) 2003-05-16 2007-12-26 Bbk Bio Corp PREPARATION FOR PREVENTING CONTACT OF PATHOGEN BROOMS WITH A LIVING ORGANISM
FR2862134B1 (fr) * 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
CN109675042B (zh) * 2019-02-01 2021-03-23 山西锦波生物医药股份有限公司 用于治疗和/或预防流感的组合物、方法和用途
RU2716003C1 (ru) * 2019-09-09 2020-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Применение сывороточного альбумина в качестве противомикробного агента

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007340A1 (en) * 1989-01-09 1990-07-12 Meiji Milk Products Co., Ltd. Anti-hiv agent

Also Published As

Publication number Publication date
ATE284222T1 (de) 2004-12-15
DE69233455T2 (de) 2005-12-22
NL9100434A (nl) 1992-10-01
JP2690813B2 (ja) 1997-12-17
ES2233923T3 (es) 2005-06-16
EP0575432A1 (en) 1993-12-29
DE69233455D1 (de) 2005-01-13
WO1992015316A1 (en) 1992-09-17
EP0575432B1 (en) 2004-12-08
JPH06505264A (ja) 1994-06-16
DK0575432T3 (en) 2005-04-04
AU1566392A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
HK1010684A1 (en) Modified proteins and their use for controlling viral infections.
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
ES2083353T3 (es) Sistema infectivo de liberacion de farmacos.
DE69738351D1 (de) Verfaheren zur durch rekombinante adeno-assoziierte virus-gerichtete gentherapie
DE3685094D1 (de) Pharmazeutisches praeparat zur kontrollierten freisetzung von wirkstoffen.
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DK476688A (da) Hiv-proteiner og -peptider, der er nyttige ved aids-diagnose, -profylakse og -terapi
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
ES2133295T3 (es) Peptidos ciclicos y su uso.
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
ATE269904T1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ES2149822T3 (es) Peptidos inmunorreactivos procedentes del virus de epstein-barr.
DE69428984D1 (de) Stimulierung der immunantwort durch virales protein
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
DE69028658D1 (de) Proteine, Vakzine und Nucleinsäuren
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
NO895154D0 (no) Fremgangsmaate ved fremstilling av et protein eller polypeptid, en dna-sekvens som koder for polypeptidet, en mikroorganisme som inneholder dna-sekvensen samt polypeptidet ogdets anvendelse som et farmasoeytisk preparat.
BR1100801A (pt) Proteìna, peptìdeo, proteìna ou peptìdeo, sequência de dna, processo para a preparação de uma proteìna ou peptìdeo, anticorpo, composição farmacêutica, e, uso de uma proteìna ou peptìdeo
ATA71388A (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090224